Multifunctional nanoparticles, quantum dots (QDs) are being developed as uniquely sensitive tools for elucidating the (bio)chemical and (bio)physical molecular mechanisms underlying functional states, i.e. the molecular physiology, of biological cells and organisms. Here we present a group of strategies and examples for (i) controlling the spectroscopic properties of QDs via Fluorescence Resonance Energy Transfer (FRET); (ii) determining the emission spectra of individual QDs in a population with an imaging spectrograph (ASI SpectraCube); and (iii) employing such liganded QDs as nano-probes in cellular studies of signal transduction.
INTRODUCTION
Nanoparticles such as Quantum Dots (QDs) can be regarded as nanotools because they are scaled to molecular dimensions, offer the required spatial and temporal resolution, and incorporate spectroscopic tags, particularly fluorescent, providing the ultimate specificity and sensitivity. The nanoparticles are excellent probes for imaging in the context of the living cell, because only microscopy offers the multidimensional resolution (spatial, temporal, parametric) with which relevant correlations can be inferred. These considerations apply to normal cells as well as to those affected by stress or disease.
Quantum dots are generally capped by a polymeric layer required for solvent (aqueous) compatibility. This layer typically provides a high number of functional groups, which we have derivatized with molecules such as photochromic compounds or fluorophores providing control over the optical properties of the nanoparticle: emission intensity and spectrum and fluorescence lifetime. Specificity in targeting a specific protein or peptide is achieved by conjugation of ligands, generally in combination with expression tags.
METHODOLOGY

FRET methods
R o , the critical Förster distance (for 50% transfer efficiency), is defined by (units, nm 6 ), where D is the quantum yield of the donor in the absence of acceptor, n is the refractive index of the medium, 2 is the orientation factor between donor and acceptor (here assigned the value of 2/3 as generally, albeit often erroneously, assumed in the literature 1 ), and J is the spectral overlap integral between donor emission and acceptor absorption, given by 
Steady-state and time-resolved spectroscopy
Steady-state fluorescence measurements were performed with Perkin Elmer (Boston, MA) LS50B and SLM (Urbana, IL) 8000S spectrofluorimeters at room temperature with 2 nm resolution. The light source for photochromic conversion was a Superlite SUV-DC-P system incorporating a 200 W DC Super-Pressure short arc lamp coupled to a light guide for high UV transmission (Lumatec GmbH, München, Germany). A UV bandpass filter (320-380 nm) was used for the photochromic forward conversion, and a green filter (510-580 nm) for the backward conversion. The irradiance at the focused output of the light guide was 3.5 mW cm -2 at 365 nm and 20 mW cm -2 at 546 nm. Time resolved determinations were carried out in time correlated single photon counting mode using a Horiba Jobin Yvon (Edison NJ) TCSPC IBH spectrometer, with a nanoLED 373 nm source and a TBX-04 detector. Excitation was with a Omega (Bratteleboro, VT) BP370 DCF 10 and emission with a Schott (Iserlohn, Germany) OG515 longpass filter.
Microscopy and hyperspectral imaging
Imaging of QDs undergoing photochromic conversions was performed on an Olympus (Hamburg, Germany) IX71 inverted fluorescence microscope, equipped with a dual illumination system: (1) Hg arc lamp and filter selector (365±10 nm, focal plane power and irradiance: 0.13 mW, 0.09 W cm -2 ; 546±10 nm, focal plane power and irradiance: 11 mW, 8 W cm -2 ), and, alternatively, (2) a Cairn Research Ltd. (Faversham, U.K.) fiber optic coupled Optosource Xenon arc lamp source and P130 Optoscan monochromator (450±15 nm, focal plane power and irradiance: 0.4 mW, 0.03 W cm -2 ). Epi-illumination was with a 570 dichroic filter and the emission was collected with a Chroma Technology (Rockingham, VT) 565±10nm filter optimized for the QD565-streptavidin conjugate quantum dots. The 60 1.45 NA oil immersion objective had a field of view of 0.4 mm. Images (0.5 s exposure) were acquired with a Sensicam electron multiplying CCD camera (a kind loan of PCO, Kelheim, Germany) at an em gain of 50. Time series of 60 images (0.5 s exposures, 10 s intervals) were acquired during irradiation at 365 and 546 nm. They were interleaved with single images excited at 450 nm. Samples were prepared on poly-L-lysine pre-coated 18 well-flat -slides (Integrated Biodiagnostics, München, Germany).
Hyperspectral imaging was performed with an Applied Spectral Imaging (Migdal Haemek, Israel) SpectraCube imaging spectrograph equipped with a VDS cool-1300 camera and mounted on the IX71 microscope. Quantum dot samples were imaged with a 150 1.45 NA objective. Excitation was with a Hg arc lamp and the epi-illumination filter Omega set consisted of 435 nm narrow bandpass excitation, 505 nm dichroic, and 510 nm longpass emission filters. Streptavidin-coated quantum dots (Quantum Dot Corp., Invitrogen, Carlsbad, CA) at 585, 605, or 655nm were diluted from the original stock concentration to final concentrations of 1 pM (QD655, PEG coated), 2 pM (QD585), or 20 fM (QD605) in PBS. Approximately 25 µl of the diluted solution was pipetted onto an Ibidi (München, Germany) 18 µ-well, poly-L lysine coated slide and allowed to bind to the surface for 5 min. The samples were washed once with water and maintained in water. A mixture of all 3 QD types was also prepared. Hyperspectral images in the range 500-800 nm were acquired in 185 s, using 128 frames (1 s exposure) and 45 interferometer steps between each frame. After Hanning windowed-Fourier transformation, single QDs were marked and classified with the ASI SpectraView software. The edge of each full field image was selected as background, and the spectrum of this area was subtracted from the individual QD spectra.
RESULTS AND DISCUSSION
Control of QD spectroscopic properties by FRET
Sensitized emission provides color changes
Commercially available QDs bioconjugated to streptavidin and titrated with biotinylated fluorophores with suitable spectral properties can be quenched efficiently by FRET 2 . Others have reported similar phenomena using QDs conjugated with maltose binding protein [3] [4] [5] . In a recent study 6 , a color change of a biosensing QDs produced by binding of a fluorescent FRET acceptor served to determine the localization of the ectodomain of erbB1, the transmembrane receptor for epidermal growth factor (EGF), undergoing retrograde transport on cellular extensions known as filopodia after activation. Streptavidin conjugated QD525 nanoparticles carrying biotinylated EGF bound to and thereby activated erbB1. The cells were exposed to biotinylated Alexa546 (a potential FRET acceptor for the QD525) applied to the external medium and capable of binding to free streptavidin sites of accessible QDs. Two phenomena were observed, both indicating that the QD-receptor complexes remained externally located, i.e were not endocytosed (into the filopodia), during retrograde transport: (i) a quenching of the QD emission due to FRET; and (ii) sensitization via FRET, as well as direct excitation, of the Alexa546 emission, manifested as a change in apparent emission color of the QD-EGF-erbB1 complexes from green to yellowish-red (Fig. 1) . Internalized QD-receptor complexes, not accessible to the Alexa546 ligand, retained their original spectral properties. Such a strategy not only serves to determine compartmentalization but also constitutes a means for selectively tagging a given QD subpopulation (see also Arndt-Jovin et al., this issue). Two additional and potentially very useful manipulations of a QD:FRET-fluorophore system can be cited: (i) photobleaching the acceptor at a location and time of choice, thereby restoring the color of the targeted QDs and establishing a cohort that can be followed over time in the living cell; (ii) augmenting the luminosity of the nanoparticles by using photostable acceptors with lifetimes shorter than that of the QDs so as to increase the net radiative rate.
Hyperpectral imaging of individual QDs with the SpectraCube imaging spectrograph
The phenomena illustrated in the previous section imply the need for accurate spectral registration of individual QDs, or clusters thereof, particularly in cellular compartments. In order to take full advantage of the potential afforded by the unique characteristics of QDs (narrow emission spectra, broad excitation range, photostability), widefield imaging using systems that generate continuous emission spectra at every pixel position is highly desirable. Fourier encoding and CCD detection combines very efficient detection and spectral reconstruction of low-light level images. We demonstrate in this publication the first application, to our knowledge, of a commercial Fourier interferometric spectrograph, the SpectraCube manufactured by Applied Spectral Imaging, for spectral imaging of individual QDs. With the very high magnification afforded by a new unique 150 1.45 NA objective in the IX71 Olympus microscope, one obtains very distinct signals attributable to QDs either attached individually to a surface (Fig. 2) or on/in cells such as those in Fig. 1 optimized for QD detection in a systematic manner. Thus, we do not attribute the apparent dispersion in the spectra of each QD type in Fig. 2 solely to inherent properties of the QD preparations, which are presumed to be relatively monodisperse. Nonetheless, in the case of the mixed QD sample, the different types of QDs were easily distinguished by the SpectraCube, confirming that the resolved signals originated from individual nanoparticles and thus establishing that the spatial resolution and spectral sensitivity clearly suffice for single QD measurements. We are currently seeking to further expand the functionality of the SpectraCube by exploiting the single-photon sensitivity of electron multiplying CCD cameras, and by incorporating arbitrary spatial and spectral ROI selection, and a double-pass configuration enabling 2D (excitation, emission) spectra and optical sectioning 7 .
Modulation of QD emission intensity by pcFRET
We have recently introduced the use of photochromic compounds as switchable acceptors for fluorescence resonance energy transfer (FRET) determinations according to a scheme we denote as photochromic FRET (pcFRET) 8, 9 . This technique was developed to overcome limitations in the quantitative determination of FRET in vivo, particularly in imaging applications. In a recent review of this subject 1 we classified pcFRET as a member of the family of so-called "acceptor depletion" methods by virtue of the induction of a reversible change in the structure and thus absorption properties of the photochromic compound (e.g. a diheteroarylethene) serving as the FRET acceptor. The key feature of pcFRET is the modulation of donor emission by cyclical transformations of the pc acceptor. The underlying phenomenon is the variation in the donor-acceptor overlap integral (and thus Förster transfer distance R o ) between the two states; the FRET efficiency depends on the 6 th power of the relative separation (r/R o ) between the donor and acceptor. Nearultraviolet illumination leads to the conversion of the colorless open form to a closed form featuring an absorption band overlapping the emission band of the fluorescent donor, and thus to a quenching of the latter (FRET on state). Cycloreversion by exposure to visible light reverses the process, i.e. restores the FRET off state.
The reversible modulation of the emission of CdSe/ZnS QDs was achieved by binding photochromic diheteroarylethenes and switchable acceptors for FRET (Fig. 3 ) 10 . A biotinylated diheteroarylethene derivative 
Selection of diheteroarylethene pcFRET acceptors
We have recently synthetized 11, 12 several families of photochromic diheteroarylethenes bearing benzothiophene, thiophene and indole groups. The spectral characteristics of the closed forms were determined by the nature of the conjugation and substitution. The absorption spectra of compounds 1-5 (Fig.  4) are shown in Fig. 5 . The selection of a photochromic acceptor is based on the overlap of its absorption bands with the emission of the QD donors. We have evaluated the characteristics of five comercial QDs (520, 565, 585, 605 and 655 nm) with a group of different photochromes (Table I ). Table I . The spectral absorption of the closed forms of the selected photochromic compounds span the emission region corresponding to the CdSe QDs. Spectral curves for the closed forms of compounds 1-5 are shown in Fig. 5B , together with the normalized emission spectra of the potential QD donors (Fig. 5A) . Compound 1 and 2 have a maximum at 516 nm, compounds 3 and 4 at 543 and 563 nm, respectively, and compound 5, bearing a methoxy group in the indole ring, at 600 nm. Compounds 1-4 possess appropriate properties for serving as switchable acceptors for QD520; i.e. R o is > 3.5 nm in the closed forms and < 2.5 nm in the open forms. Similarly, compounds 1-5 can serve as acceptors for QD565. The spectral overlap is highest for compound 4, which has an R o of 4.7 nm. In the case of the QD655, the compound that provides the best overlap is number 5.
In the experiments featured below (Figs. 6 and 7) , we selected as donor-acceptor pair QD565 and a derivative of compound 3 (Fig. 4) (Fig. 6 ), QD565-ITK (QD preparations lacking surface PEG and thus better suited for FRET) displayed a decay that was fit to a biexponential function ( 1 = 20 ns; 83% amplitude; 2 = 2.4 ns, 17% amplitude). After photoconversion pf the acceptor to the closed form, the steady-state intensity of the QD donor diminished by 68%, paralleled by a corresponding reduction in the lifetimes ( 1 = 9.5 ns; 53% amplitude; 2 = 1.75 ns, 47% amplitude). The efficiency E corresponding to the open form was very low (0.05). The upper limit of E (for the closed acceptor form) increases further in the case of multiple acceptors (n >1) bound to the QD. 
Cyclic modulation of QD donor fluorescence monitored by imaging
Streptavidin-conjugated magnetic microspheres (Dynal, Invitrogen) were bound to polylysine-coated coverslips ( -slides). The microspheres were then saturated with bis-biotin, washed, and exposed to a QD565-streptavidin suspension. The -slides were thereby covered with sparsely distributed 2.6 m magnetic beads, each of which was coated with QDs bridged to the carrier microspheres via bis-biotin, and by individual and clustered QDs spread randomly over the surface. After washing, the slides were exposed to saturating levels of photochromic compound 3 (Fig. 4) . bound to polylysine-covered coverslips, washed with PBS (20 mM Na-phosphate, 150 mM NaCl, pH 7.2) and incubated for 10 min with 2.6 M bis-biotin, 10 min with QD565-streptavidin in PBS, and 10 min with 2.5 µM biotin-DAE in PBS; each incubation was followed by 3 washes with PBS. Surface plots of a selected region containing aggregates and single QDs. The surface exhibited fluorescence shells (QDs coated microspheres), and single and aggregated QDs. After a pre-irradiation period with UV and visible light the QDs displayed a reproducible decrease of emission upon irradiation with UV light (as a result of pcFRET) and an increase of emission when irradiated with visible light. The first exposure to UV light resulted in an increase of QD emission (representing a QD "curing" process), also observed in the spectroscopy measurements. After this equilibration phase, subsequent alternating exposures to UV and visible irradiation produced systematic decreases and increases, respectively, in QD emission. The latter achieved the same initial value after each cycle. We determined the kinetics of the forward conversion to the closed form and its cycloreversion under the given experimental conditions, from a series of images acquired during UV and visible irradiation. The kinetic curves were reproducible. Figure 7 features surface views corresponding to four cycles of photoconversion of a selected region. The initial and final states were monitored by imaging with low-level 450 nm excitation. The QD intensity exhibited a dramatic modulation, with an almost 100% decrease in emission intensity with the FRET-active state of the photochromic acceptor.
